Analyst Price Targets — ENOV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 26, 2026 8:48 pm | Mike Matson | Needham | $52.00 | $25.42 | StreetInsider | Enovis Corp (ENOV) PT Raised to $52 at Needham |
| January 6, 2026 11:21 am | Ryan Zimmerman | BTIG | $41.00 | $27.01 | TheFly | Enovis initiated with a Buy at BTIG |
| January 5, 2026 2:50 pm | — | Evercore ISI | $40.00 | $26.66 | TheFly | Enovis price target lowered to $40 from $44 at Evercore ISI |
| January 5, 2026 2:19 pm | Danielle Antalffy | UBS | $50.00 | $27.47 | StreetInsider | Enovis Corp (ENOV) PT Lowered to $50 at UBS, Estimates Updated |
| December 17, 2025 12:24 pm | — | Canaccord Genuity | $50.00 | $26.07 | TheFly | Enovis price target lowered to $50 from $58 at Canaccord |
| November 6, 2024 6:23 pm | Mike Matson | Needham | $65.00 | $43.32 | StreetInsider | Needham Reiterates Buy Rating on Enovis Corp (ENOV) |
| July 2, 2024 8:02 am | Vijay Kumar | Evercore ISI | $62.00 | $44.35 | TheFly | Enovis price target lowered to $62 from $70 at Evercore ISI |
| May 3, 2024 6:25 am | Jeff Johnson | Robert W. Baird | $64.00 | $52.13 | StreetInsider | Enovis Corp (ENOV) PT Lowered to $64 at Baird |
| December 15, 2023 2:38 pm | Mike Matson | Needham | $70.00 | $53.58 | Benzinga | This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch |
| May 12, 2023 5:56 am | Vik Chopra | Wells Fargo | $67.00 | $55.79 | StreetInsider | Wells Fargo Upgrades Enovis Corp (ENOV) to Overweight |
Latest News for ENOV
Enovis (ENOV) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.81 per share a year ago.
Dallas, TX, May 07, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended April 3, 2026. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.
Enovis (ENOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
On April 28, 2026, Enovis Corp (ENOV) shares fell 4.7% today, closing at $23.40. The stock has experienced a 52-week range of $21.00 to $37.85, indicating signi
Omnicell (OMCL) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.26 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ENOV.
U.S. House Trading
No House trades found for ENOV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.